Guidelines for the Treatment of Parkinson's Disease in China (Fourth Edition) (1)

Parkinson’s disease is a common degenerative disease of the nervous system in middle-aged and elderly people. In recent years, Chinese scholars have learned about the pathogenesis of Parkinson’s disease, the discovery of biomarkers for early diagnosis, or the update of treatment concepts and treatment methods. And the exploration of methods has made significant progress. The Parkinson's Disease and Movement Disorders Group of the Neurology Branch of the Chinese Medical Association formulated the first, second and third editions of the Chinese Parkinson's Disease Treatment Guidelines in 2006, 2009 and 2014. In the past six years, there have been some renewal of treatment concepts and advances in treatment methods in this treatment field at home and abroad. In order to better adapt to its development, guide

Translation-2018 Lancet meta 21 antidepressant meta-analysis

Major depressive disorder is the most common and common mental illness that brings huge mental and economic burden to patients. Current treatment methods include drug therapy and non-drug therapy; however, due to the limited resources of psychotherapy, the use rate of antidepressants is higher than that of psychological intervention. The clinical application of these antidepressants should be based on the best empirical evidence available.